Wegovy Insurance Coverage in Canada 2026: Provincial Plans, Private Insurance and Prior Authorization

Wegovy insurance coverage in Canada is a confusing, province-by-province patchwork. Some Canadians pay nothing out of pocket. Others are stuck with the full retail price, which can top $400 per month. This guide breaks down which provincial drug plans cover Wegovy, what private insurers require, how prior authorization works, and the exact steps you can take right now to get your treatment covered. If you are wondering whether your plan will pay for Wegovy, you are in the right place.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider or pharmacist before starting, stopping, or changing any medication. Insurance coverage policies change frequently. Confirm your specific coverage with your insurer or provincial drug plan.

How Wegovy Insurance Coverage Works in Canada

Wegovy (semaglutide 2.4 mg) received Health Canada approval for chronic weight management in 2024, and since then, the insurance picture has been evolving fast. Unlike many prescription drugs that get listed on provincial formularies within months, weight management medications tend to face longer review timelines and stricter criteria. [1]

Getting Wegovy covered is not always straightforward. Each province has its own drug plan with its own rules. Private insurers set their own criteria on top of that. And the prior authorization process can feel like a paper chase if you are not prepared.

Why Coverage Varies So Much Across Canada

Canada does not have a single national pharmacare program for prescription drugs (yet). Each province and territory operates its own public drug benefit plan. The Canadian Agency for Drugs and Technologies in Health (CADTH, now CDA-AMC) reviews new drugs and issues recommendations, but provinces are free to accept, modify, or reject those recommendations. [2]

CADTH completed its review of Wegovy and issued a conditional recommendation for reimbursement with clinical criteria. That recommendation opened the door for provincial listings, but each province still had to make its own decision about if and how to list the drug. [2]

This means a Canadian in one province might have Wegovy fully covered while someone in another province pays full price. It is the same country, the same drug, and a very different financial reality.

Provincial Drug Plan Coverage for Wegovy

Here is where things stand across Canada as of early 2026. Provincial formulary decisions are ongoing, so check your provincial drug plan website for the most current status.

Provincial Coverage Comparison Table

Province/Territory | Coverage Status | Key Conditions | Notes

---|---|---|---

British Columbia | Limited coverage (Special Authority) | BMI 30+ or BMI 27+ with comorbidity, failed lifestyle intervention | Requires Special Authority application through PharmaCare

Alberta | Under review | Pending provincial formulary decision | Some patients accessing through individual case-by-case requests

Saskatchewan | Not listed | No public plan coverage at this time | Private insurance or out-of-pocket only

Manitoba | Not listed | No public plan coverage at this time | Pharmacare program does not include Wegovy

Ontario | Limited coverage (Exceptional Access Program) | BMI 35+ or BMI 30+ with type 2 diabetes or cardiovascular disease | Approval through Ontario Drug Benefit Exceptional Access Program

Quebec | Listed with restrictions (RAMQ) | BMI 30+ with comorbidity, physician specialist referral | RAMQ listing with prior authorization, 12-month initial approval

New Brunswick | Not listed | No public plan coverage | Patients rely on private insurance

Nova Scotia | Under review | Pending Pharmacare formulary decision | Expected decision in 2026

Prince Edward Island | Not listed | No public plan coverage | Small formulary, weight management drugs not covered

Newfoundland and Labrador | Not listed | No public plan coverage | NLPDP has not listed Wegovy

Northwest Territories | Case-by-case | May be approved on individual basis | Extended health benefits may apply for eligible residents

Yukon | Case-by-case | Individual assessment through Pharmacare | Contact Yukon Pharmacare for eligibility

Nunavut | Case-by-case | Individual assessment required | Contact territorial health benefits office

Provinces with Active Coverage

Quebec is the most accessible province for public coverage right now. The Régie de l'assurance maladie du Québec (RAMQ) added Wegovy to its formulary with restrictions. You need a BMI of 30 or higher with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, or dyslipidemia). Your prescribing physician submits the prior authorization, and approvals typically come through within 2 to 4 weeks. [3]

British Columbia offers coverage through PharmaCare's Special Authority process. The criteria are slightly broader than Ontario's, accepting patients with a BMI of 30+ or a BMI of 27+ with a comorbidity. Your doctor fills out the Special Authority request form, and the BC PharmaCare program reviews it. [4]

Ontario covers Wegovy through the Exceptional Access Program (EAP), but the bar is higher. You generally need a BMI of 35 or above, or a BMI of 30+ with type 2 diabetes or established cardiovascular disease. The application goes through the Ontario Drug Benefit program, and wait times for approval can stretch to 4 to 8 weeks. [5]

Provinces Without Coverage

Saskatchewan, Manitoba, New Brunswick, PEI, and Newfoundland and Labrador do not currently list Wegovy on their public formularies. If you live in one of these provinces, your options are private insurance, employer benefits, or paying out of pocket. You can learn more about pricing in the Wegovy cost guide.

Private Insurance Coverage for Wegovy in Canada

Private insurance is where most working Canadians access Wegovy coverage. Employer-sponsored group benefit plans and individual health insurance policies each handle weight management drugs differently.

From pharmacist and prescriber reports across Canada, private coverage expanded in 2025 and 2026. More insurers are adding Wegovy to their formularies, partly driven by the growing body of cardiovascular outcome data from the SELECT trial. [6]

Private Insurer Coverage Table

Coverage criteria vary widely by insurer and even by employer plan. Below is a general guide to where the major Canadian insurers stand on Wegovy in 2026.

If your employer plan covers all DIN-listed medications without a restricted formulary, Wegovy is likely covered automatically. Call the number on your insurance card to confirm.

What If Your Private Insurance Denies Wegovy Coverage?

First-round denials are common, especially for weight management indications. Many denials are overturned on appeal. The steps:

• Ask for the denial reason in writing.

• Have your prescriber submit a detailed letter of medical necessity that addresses the specific denial reason and includes BMI, comorbidities, and any prior weight management attempts.

• File a formal appeal within the insurer's deadline (typically 30 to 90 days).

• Contact your provincial insurance regulator if the appeal fails.

• Consider provincial safety-net programs (e.g., Trillium Drug Program in Ontario) and the NovoCare patient support program. [7]

Cost of Wegovy With vs. Without Insurance

Wegovy retails for roughly $540 to $570 per month at most Canadian pharmacies. Here is what you can expect to pay in 2026 across different coverage scenarios.

If you are paying full retail, see our Wegovy savings card guide for strategies to reduce monthly cost. Note: the recent Health Canada approvals of generic semaglutide (Dr. Reddy's on April 28, 2026 and Apotex on May 1, 2026) apply to the Ozempic indication for type 2 diabetes. Wegovy is sold for chronic weight management and is not interchangeable with the new generics under their current Health Canada authorizations, so Wegovy pricing is not affected by these approvals.

Generic Semaglutide at In-Person Canadian Pharmacies

Cash retail prices for generic semaglutide at Canadian pharmacies are now coming in below the telehealth alternatives, based on early Canadian consumer reports. Costco Pharmacy is the lowest reliable option at roughly $88 to $99 per month (confirmed pickups: $88.88 GTA, $88 Ontario, $99 Laval, $91 Medicine Hat). Walmart and Loblaws No Frills typically come in around $95 to $110 per month. Shoppers Drug Mart, Rexall and London Drugs are running roughly $100 to $120 per month (one Halifax-area Shoppers fill reported $113 for the 0.25mg starter dose). Apotex's Apo-Semaglutide Injection began shipping to Canadian pharmacies on May 20, 2026, with Dr. Reddy's generic also launching in May 2026.

That makes in-person pharmacies — especially Costco — meaningfully cheaper than telehealth providers for generic semaglutide. Felix Health and Hims Canada both list $149 per month all-in for the same generic Apo-Semaglutide on their public pricing pages. For most Canadians with a valid prescription, walking it into a local pharmacy is now the cheapest reliable path.

Pricing context: per the Globe and Mail, Apotex's published wholesale price is $78.14 for a four-week supply — roughly one-third of brand-name Ozempic's $240.48 wholesale price. Retail estimates above reflect that wholesale plus each chain's standard dispensing fee and markup. See also coverage from CBC News on the Canadian launch. Note: The May 2026 generic launch covers the Ozempic indication for type 2 diabetes only. Generic Wegovy (semaglutide 2.4 mg for chronic weight management) is not yet available — Novo Nordisk holds additional patents on the high-dose formulation. Under the pan-Canadian Pharmaceutical Alliance framework, the maximum public drug plan price for generic semaglutide is approximately $114 per four-week supply with two manufacturers approved, dropping to roughly $80 once a third manufacturer launches.

Step-by-Step: How to Get Wegovy Insurance Coverage

Whether you are going through a provincial plan or private insurance, the process follows the same general arc:

Have your physician's office follow up after about 2 weeks. A short phone call to the insurer can often speed up processing.

Online Providers Cost Comparison

Most Canadians now access Wegovy through telehealth providers rather than in-person clinics. Below is how the main Canadian online providers compare for Wegovy prescribing, with MyRocky now our highest-rated GLP-1 provider overall.

MyRocky is our highest-rated Canadian GLP-1 telehealth provider in 2026 (9.4/10). MyRocky operates its own LegitScript-certified pharmacy in Mississauga, employs Canadian-licensed MDs, nurse practitioners and pharmacists, and serves all 10 provinces (including Quebec and New Brunswick where Felix and Hims do not). The $99 one-time consultation includes lab work and the first prescription. Read our full MyRocky review.

Frequently Asked Questions

Is Wegovy covered by my provincial drug plan?

It depends on your province. Quebec (RAMQ), British Columbia (PharmaCare), and Ontario (EAP) offer restricted public coverage with BMI and comorbidity criteria. Most other provinces do not list Wegovy on their public formularies as of 2026. Check the provincial coverage table above for the latest status.

How much does Wegovy cost in Canada without insurance?

Wegovy costs roughly $540 to $570 per month at most Canadian pharmacies for the 2.4 mg maintenance dose, plus a dispensing fee of $4 to $12. Costco Pharmacy is consistently the cheapest option, no membership required.

What BMI do I need for Wegovy coverage?

Most public and private plans require a BMI of 30 or higher, or 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, sleep apnea, dyslipidemia, cardiovascular disease). Ontario's Exceptional Access Program sets the bar higher at BMI 35+ or 30+ with diabetes or established cardiovascular disease.

Will the new generic semaglutide approvals lower Wegovy's price?

Not directly. The Dr. Reddy's and Apotex generics approved in late April and early May 2026 apply to the Ozempic indication for type 2 diabetes, not to Wegovy. Wegovy is sold for chronic weight management and the generics are not interchangeable substitutes under their current Health Canada approvals. See our generic semaglutide guide for the full picture.

How long does prior authorization for Wegovy take?

Most private insurer prior authorizations process in 2 to 4 weeks. BC PharmaCare's Special Authority averages 2 to 3 weeks. Ontario's Exceptional Access Program is the slowest, often 4 to 8 weeks. Submitting all documentation at once (form, BMI history, comorbidities, prior weight management attempts) is the single best way to avoid delays.

Sources

• Wegovy (semaglutide 2.4 mg) Product Information — Novo Nordisk Canada — Health Canada–approved indication for chronic weight management; product details and authorization information for the Wegovy 2.4 mg dose.

• Reimbursement Review: Semaglutide (Wegovy) — Canada's Drug Agency (CDA-AMC, formerly CADTH) — National reimbursement recommendation and clinical criteria used by provincial drug plans when listing Wegovy.

• Quebec Public Prescription Drug Insurance Plan — Régie de l'assurance maladie du Québec (RAMQ) — RAMQ formulary listings, médicament d'exception criteria, and prior-authorization process used for Wegovy in Quebec.

• BC PharmaCare Publications and Special Authority — British Columbia Ministry of Health — BC PharmaCare Special Authority criteria, request forms, and adjudication process for Wegovy coverage in British Columbia.

• Ontario Drug Benefit Program and Exceptional Access Program (EAP) — Government of Ontario — Ontario Drug Benefit eligibility, Exceptional Access Program (EAP) process, and BMI-and-comorbidity criteria used for Wegovy approvals.

• Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT Trial) — Lincoff et al., New England Journal of Medicine, November 2023 — Phase 3 randomized trial showing semaglutide 2.4 mg (Wegovy) reduced major cardiovascular events versus placebo, a key driver of recent private-insurer formulary expansions.

• Trillium Drug Program — Government of Ontario — Ontario safety-net program for households with high prescription drug costs relative to income; can offset out-of-pocket Wegovy spend after the Trillium deductible.